Hydrocephalus, Normal Pressure
12
0
3
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
Role of Brain Specific Biomarkers in Hydrocephalus
Volumetrics and Proteomics in Shunted Normal Pressure Hydrocephalus
MRI-Volumetry in the Evaluation of Shunt Treatment for Hydrocephalus
Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
Diagnostic Accuracy of ShuntCheck Compared to Radionuclide Shunt: Patency in Patients With Normal Pressure Hydrocephalus
Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus
Ventriculomegaly and Gait Disturbance in the Senior Population in the Region of Västerbotten
Effects of Physical Training in iNPH
A Study Comparing Shunt Placement Versus Endoscopic Third Ventriculostomy in the Treatment of Hydrocephalus
Vascular Risk Factors in INPH-patients